STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Schedule 13G/A: 447,232 TuHURA Shares Disclosed by CA Patel F&F

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

TuHURA Biosciences, Inc. reported that CA Patel F&F Investments, LLC beneficially owned 447,232 shares of the companys common stock as of June 12, 2025. That holding represents 0.9% of the outstanding class, calculated using 50,046,926 shares reported by the issuer as outstanding on August 11, 2025. The filing states the reporting person has sole voting and dispositive power over all 447,232 shares and that the shares were not acquired to influence control of the company.

The Schedule 13G/A provides the filers business address in Tampa, Florida, and is signed by Adam Baals as Manager of CA Patel F&F Investments, LLC on August 14, 2025.

Positive

  • Transparent disclosure of beneficial ownership and voting/dispositive powers
  • Position clearly characterized as passive, not acquired to influence control

Negative

  • None.

Insights

TL;DR: Passive stake disclosed; <0.9% ownership is immaterial to control or valuation.

The filing documents a small, passive position of 447,232 shares, equal to 0.9% of TuHURAs outstanding common stock based on the issuers reported share count. For investors, a sub-1% position typically indicates no near-term influence on corporate strategy or control. The declaration of sole voting and dispositive power clarifies voting responsibility but does not imply coordination with other holders. This disclosure improves transparency but is unlikely to move market perceptions absent further accumulation or related filings.

TL;DR: Governance impact is minimal; filing affirms passive intent and voting authority.

The Schedule 13G/A explicitly states the securities were not acquired to influence control and includes the certificate that the position is passive. The reporters sole voting and dispositive power is noted, which is important for vote-tracking, but a 0.9% stake does not create practical governance influence. The timely amendment and signature by the manager satisfy disclosure obligations under the Exchange Act.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 447,232 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer. * Percent of class is calculated based on 50,046,926 shares of Common Stock outstanding as of August 11, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on August 14, 2025. The percentage of ownership was calculated in accordance with Rule 13d-3(d)(1)(i) promulgated under the Securities Exchange Act of 1934, as amended.


SCHEDULE 13G



CA Patel F&F Investments, LLC
Signature:/s/ Adam Baals
Name/Title:Adam Baals, Manager
Date:08/14/2025

FAQ

Who filed the Schedule 13G/A for TuHURA Biosciences (issuer)?

The filing was made by CA Patel F&F Investments, LLC with business address 5600 Mariner St., Ste. 200, Tampa, FL 33609.

How many TuHURA shares does CA Patel F&F Investments, LLC beneficially own?

447,232 shares of common stock as of June 12, 2025.

What percentage of TuHURA's common stock does the reported stake represent?

The stake represents 0.9% of the class, calculated using 50,046,926 shares outstanding reported as of August 11, 2025.

Does the filer have voting or dispositive control over the shares?

Yes, the filer reports sole voting power and sole dispositive power over all 447,232 shares.

Was the position acquired to influence control of TuHURA?

No. The certification states the securities were not acquired to change or influence control of the issuer.
Kintara Therapeutics, Inc.

NASDAQ:KTRA

KTRA Rankings

KTRA Latest News

KTRA Latest SEC Filings

KTRA Stock Data

11.99M
55.66M
Polish and Other Sanitation Good Manufacturing
Pharmaceutical Preparations
Link
US
SAN DIEGO